Human inborn errors of immunity: an expanding universe

LD Notarangelo, R Bacchetta, JL Casanova… - Science …, 2020 - science.org
Molecular, cellular, and clinical studies of human inborn errors of immunity have
revolutionized our understanding of their pathogenesis, considerably broadened their …

Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease

W Zhang, X Liu, Y Zhu, X Liu, Y Gu… - European Journal of …, 2021 - Wiley Online Library
Regulatory T (Treg) cells and T helper type 17 (Th17) cells play important roles in adaptive
immune responses, antagonizing each other in immune disorders. Th17/Treg balance is …

High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails

BR Shy, VS Vykunta, A Ha, A Talbot, TL Roth… - Nature …, 2023 - nature.com
Enhancing CRISPR-mediated site-specific transgene insertion efficiency by homology-
directed repair (HDR) using high concentrations of double-stranded DNA (dsDNA) with …

Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation

C Selck, M Dominguez-Villar - Frontiers in immunology, 2021 - frontiersin.org
Regulatory T (Treg) cells are a heterogenous population of immunosuppressive T cells
whose therapeutic potential for the treatment of autoimmune diseases and graft rejection is …

Gene therapy for inborn errors of immunity: past, present and future

A Fischer - Nature Reviews Immunology, 2023 - nature.com
Inborn errors of immunity (IEI) are diseases caused by genetic mutations that affect the
immune system's ability to fight pathogens, cope with the microbiota or regulate …

Eras of designer Tregs: Harnessing synthetic biology for immune suppression

K Tuomela, K Salim, MK Levings - Immunological Reviews, 2023 - Wiley Online Library
Since their discovery, CD4+ CD25hiFOXP3hi regulatory T cells (Tregs) have been firmly
established as a critical cell type for regulating immune homeostasis through a plethora of …

Therapeutic gene editing of T cells to correct CTLA-4 insufficiency

TA Fox, BC Houghton, L Petersone, E Waters… - Science Translational …, 2022 - science.org
Heterozygous mutations in CTLA-4 result in an inborn error of immunity with an autoimmune
and frequently severe clinical phenotype. Autologous T cell gene therapy may offer a cure …

[HTML][HTML] Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression

KP Mueller, NJ Piscopo, MH Forsberg… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Chimeric antigen receptor (CAR) T cells have demonstrated high clinical
response rates against hematological malignancies (eg, CD19+ cancers) but have shown …

[HTML][HTML] The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

N Guo, JB Liu, W Li, YS Ma, D Fu - Journal of Advanced Research, 2022 - Elsevier
Abstract Background Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
is derived from the bacterial innate immune system and engineered as a robust gene-editing …

Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations

Š Borna, E Lee, J Nideffer, A Ramachandran… - Science translational …, 2023 - science.org
Studies of the monogenic autoimmune disease immunodysregulation polyendocrinopathy
enteropathy X-linked syndrome (IPEX) have elucidated the essential function of the …